Interestingly, the levels of the semaphorin receptor Neuropilin-1 (NRP-1) in BM biopsies of patients with newly diagnosed, untreated, AML were significantly increased compared those found in normal controls; and in fact higher level of NRP-1 were associated with poor overall survival (25). This evidence concerns the gene NRP1 and acute myeloid leukemia.